Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 911-351-2 | CAS number: -
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 15 February to 19 March 2012.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD 471 guideline study in compliance with the GLP. No deviation from the protocol of the study.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Deviations:
- not specified
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- 2011-08-31
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Reaction Mass of Diisobutyl hydrogen phosphate and Isobutyl dihydrogen phosphate (IBAP)
- IUPAC Name:
- Reaction Mass of Diisobutyl hydrogen phosphate and Isobutyl dihydrogen phosphate (IBAP)
- Reference substance name:
- (2-methylpropoxy)phosphonic acid; bis(2-methylpropoxy)phosphinic acid
- EC Number:
- 911-351-2
- Molecular formula:
- Not applicable
- IUPAC Name:
- (2-methylpropoxy)phosphonic acid; bis(2-methylpropoxy)phosphinic acid
- Test material form:
- other: Extremely pale yellow viscous liquid
- Details on test material:
- - Name of test material (as cited in study report): Isobutyl acid phosphate (IBAP)
- Physical state: pale yellow viscous liquid
- Stability under test conditions: the test item is assumed to be stable by the sponsor.
- Storage condition of test material: room temperature in the dark.
Constituent 1
Constituent 2
Method
- Target gene:
- Histidine for Salmonella.
Tryptophan for E.Coli
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- Not applicable.
- Additional strain / cell type characteristics:
- other: see Table 7.6.1/1
- Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- Not applicable.
- Additional strain / cell type characteristics:
- other: see Table 7.6.1/1
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 from induced phenobarbitone/betanaphthoflavone rat liver.
- Test concentrations with justification for top dose:
- Preliminary Toxicity Test: 0, 0.15, 0.5, 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate
Experiment I: 15, 50, 150, 500, 1500 and 5000 µg/plate
Experiment II: 5, 15, 50, 150, 500, 1500 and 5000 µg/plate
Formulated concentrations were adjusted to allow for the stated water/impurity content (4%) of the test item. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Dimethyl sulphoxide (DMSO).
- Justification for choice of solvent/vehicle: The test item was immiscible in sterile distilled water at 25 and 50 mg/ml but was fully miscible in
dimethyl sulphoxide at 50 mg/ml in solubility checks performed in-house. Dimethyl sulphoxide was therefore selected as the vehicle.
Controls
- Untreated negative controls:
- yes
- Remarks:
- (untreated)
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Dimethyl sulphoxide
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- benzo(a)pyrene
- other: 2-Aminoanthracene: 1 µg/plate
- Remarks:
- See Table 7.6.1/2
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
- In agar (plate incorporation): in the Range Finding Test as well as in the Experiment 1.
- Pre-incubation: in Experiment 2
DURATION
- Incubation period: at 37°C for 48 hours
- Preincubation period: 20 min at 37°C
NUMBER OF REPLICATIONS: Triplicate plating. Two independent experiments were performed.
DETERMINATION OF CYTOTOXICITY
- Method: the cytotoxicity of the test material was determined using TA100 and WP2uvrA in the presence and absence of metabolic activation system with appropriate untreated and a vehicle control (DMSO). The concentrations examined were 5000, 1500, 500, 150, 50, 15, 5, 1.5, 0.5, 0.15 and 0 µg/plate. After approximately 48 hours incubation at 37°C the plates were assessed for numbers of revertant colonies using a Domino colony counter and examined for effects on the growth of the bacterial background lawn. - Evaluation criteria:
- Acceptance Criteria:
The reverse mutation assay may be considered valid if the following criteria are met:
- All tester strain cultures exhibit a characteristic number of spontaneous revertants per plate in the vehicle and untreated controls.
- The appropriate characteristics for each tester strain have been confirmed, eg rfa cell-wall mutation and pKM101 plasmid R-factor etc.
- All tester strain cultures should be in the approximate range of 0.9 to 9 x 1000000000 bacteria per ml.
- Each mean positive control value should be at least twice the respective vehicle control value for each strain, thus demonstrating both the intrinsic
sensitivity of the tester strains to mutagenic exposure and the integrity of the S9-mix.
- There should be a minimum of four non-toxic test material dose levels.
- There should not be an excessive loss of plates due to contamination.
Evaluation criteria:
- Criteria for a Positive Response:
A test item was considered mutagenic if:
- A dose-related increase in revertant frequency over the dose range tested and/or;
- A reproducible increase at one or more concentrations in at least one bacterial strain with or without metabolic activation.
- Biological relevance of the results will be considered first, statistical methods, as recommended by the UKEMS can also be used as an aid to evaluation, however, statistical significance will not be the only determining factor for a positive response.
- Criteria for a Negative Response
A test material will be considered non-mutagenic in the test system if the above criteria are not met. - Statistics:
- Standard deviation
Dunnett's Linear Regression Analysis
Results and discussion
Test resultsopen allclose all
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: The test item was immiscible in sterile distilled water at 25 and 50 mg/ml but was fully miscible in dimethyl sulphoxide at 50 mg/ml in solubility checks performed in-house. Dimethyl sulphoxide was therefore selected as the vehicle.
- Precipitation: No test item precipitate was observed on the plates at any of the doses tested in either the presence or absence of S9-mix.
RANGE-FINDING/SCREENING STUDIES:
Preliminary Toxicity Test:
The test item exhibited weakened background lawns to both strains (TA100 and WP2uvrA) at 5000 µg/plate in the absence and presence of S9-mix.
COMPARISON WITH HISTORICAL CONTROL DATA:
Prior to use, the master strains were checked for characteristics, viability and spontaneous reversion rate (all were found to be satisfactory).
Results for the negative controls (spontaneous mutation rates) were considered to be acceptable.
All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies thus confirming the activity of the S9-mix and the sensitivity of the bacterial strains.
ADDITIONAL INFORMATION ON CYTOTOXICITY: In the first experiment (plate incorporation method) the test item caused a visible reduction in the
growth of the bacterial background lawns of all of the tester strains at 5000 µg/plate in both the absence and presence of S9-mix. In the second
experiment (pre-incubation method) the test item induced a weaker toxic response with weakened bacterial background lawns noted at
5000 µg/plate to TA1537 only in both the absence and presence of S9-mix. The sensitivity of the bacterial tester strains to the toxicity of the test
item varied between strain type and experimental methodology. These results were not indicative of toxicity sufficiently severe enough to prevent the test item being tested up to the maximum recommended dose level of 5000 µg/plate.
Any other information on results incl. tables
Table 7.6.1/3:Summary Table of the Experiment I (with and without metabolic activation)
Concentrations |
Mean |
Salmonella typhimuriumtester strains |
Escherichia coli |
||||||||
TA98 |
TA100 |
TA1535 |
TA1537 |
WP2uvrA |
|||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
||
0 |
Mean |
18 |
29 |
97 |
109 |
27 |
13.0 |
9 |
10 |
31 |
36 |
SD |
3.2 |
6.1 |
16.5 |
2.3 |
2.5 |
1.2 |
3.1 |
3.5 |
0.6 |
1.5 |
|
15 |
Mean |
20 |
29 |
87 |
111 |
21 |
9 |
8 |
11 |
32 |
38 |
SD |
1.7 |
5.3 |
6.0 |
8.7 |
5.5 |
1.2 |
3.5 |
4.5 |
3.5 |
7.0 |
|
50 |
Mean |
19 |
17 |
80 |
100 |
15 |
12 |
8 |
9 |
30 |
32 |
SD |
5.3 |
4.4 |
16.8 |
7.8 |
3.2 |
6.2 |
4.0 |
4.7 |
4.0 |
4.6 |
|
150 |
Mean |
25 |
22 |
100 |
105 |
21 |
12 |
7 |
12 |
29 |
37 |
SD |
4.0 |
2.5 |
15.9 |
14.7 |
4.0 |
6.2 |
2.1 |
5.0 |
2.1 |
0.6 |
|
500 |
Mean |
14 |
24 |
80 |
84 |
16 |
13 |
8 |
12 |
31 |
41 |
SD |
6.1 |
7.8 |
5.1 |
11.0 |
2.5 |
5.9 |
1.5 |
3.2 |
4.9 |
2.0 |
|
1500 |
Mean |
14 |
18 |
90 |
79 |
21 |
9 |
5 |
9 |
37 |
34 |
SD |
1.7 |
2.5 |
7.2 |
5.0 |
0.6 |
0.6 |
2.1 |
1.0 |
2.1 |
4.9 |
|
5000 |
Mean |
15 |
16 |
117 |
79 |
14 |
13 |
5 |
5 |
30 |
27 |
SD |
2.3 |
2.0 |
9.1 |
5.0 |
4.6 |
2.5 |
2.3 |
0.6 |
1.0 |
1.2 |
|
ENNG |
Mean |
- |
- |
407 |
- |
85 |
- |
- |
- |
518 |
- |
SD |
- |
- |
19.1 |
- |
3.6 |
- |
- |
- |
45.2 |
- |
|
4NQO (0.2 µg/plate) |
Mean |
103 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
SD |
11.1 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
9AA (80 µg/plate) |
Mean |
-- |
- |
-- |
- |
-- |
- |
577 |
- |
-- |
-- |
SD |
-- |
- |
-- |
- |
-- |
- |
111.4 |
- |
-- |
-- |
|
2AA |
Mean |
-- |
-- |
-- |
1384 |
-- |
319 |
-- |
234 |
-- |
349 |
MF |
-- |
-- |
-- |
66.9 |
-- |
18.6 |
-- |
37.1 |
-- |
23.5 |
|
BP (5µg/plate) |
Mean |
-- |
225 |
- |
-- |
- |
-- |
-- |
-- |
-- |
-- |
MF |
-- |
12.7 |
- |
-- |
- |
-- |
-- |
-- |
-- |
-- |
|
Notes: ENNG; N-ethyl-N’-nitro-N-nitrosoguanidine; 4NQO; 4-Nitroquinoline-1-oxide; 2AA: 2-aminoanthracene; 9AA: 9-aminoacridine; BP; Benzo(a)pyrene;
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results:
negative (with and without metabolic activation)
Under the test conditions of this study, the test item Reaction Mass of "Diisobutyl hydrogen phosphate and Isobutyl phosphate" (IBAP) had no mutagenic activity in the applied bacterium tester strains. - Executive summary:
In a reverse gene mutation assay in bacteria, performed according to the OECD No.471 guideline and in compliance with GLP, the Reaction Mass of "Diisobutyl hydrogen phosphate and Isobutyl phosphate" (IBAP) diluted in Dimethyl sulphoxide (DMSO) was tested in S. typhimurium TA1535, TA1537, TA100 and TA98 and in E. coli WP2 uvr A in the presence and the absence of mammalian metabolic activation (S9) using the direct incorporation or the preincubation method. Six known mutagens (4-nitroquinoline-N-oxide; 9-Aminoacridine; N-ethyl-N-nitro-N-nitrosoguanidine; 2-Aminoanthracene and Benzoapyrene), dissolved in dimethylsulfoxide, were used to check the sensitivity of the test system.
A preliminary study (one plate/concentration) was performed in order to determine the appropriate concentrations for the two independent main studies (3 plates/concentration). In the preliminary study, the bacterial strains TA100 and WP2 uvrA were exposed to the test substance at the following concentrations: 0,0.15,0.5, 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate. The test item was freely soluble up to the highest tested concentration. Cytotoxicity, assessed by the decrease in the number of revertants and/or the thinning of the bacterial lawn, was observed in all strains. The test item exhibited weakened background lawns to both strains (TA100 and WP2uvrA) at 5000 µg/plate in the absence and presence of S9-mix. Therefore, 5000 µg/plate was chosen as the highest tested concentration for the main study.
In the first experiment (plate incorporation method; 15, 50, 150, 500, 1500 and 5000 µg/plate) the test item caused a visible reduction in the growth of the bacterial background lawns of all of the tester strains at 5000 µg/plate in both the absence and presence of S9-mix. In the second experiment (pre-incubation method with S9 mix, direct plate incorporation without S9 mix; 5, 15, 50, 150, 500, 1500 and 5000 µg/plate) the test item induced a weaker toxic response with weakened bacterial background lawns noted at 5000 µg/plate to TA1537 only in both the absence and presence of S9-mix. The sensitivity of the bacterial tester strains to the toxicity of the test item varied between strain type and experimental methodology. These results were not indicative of toxicity sufficiently severe enough to prevent the test item being tested up to the maximum recommended dose level of 5000 µg/plate. No test item precipitate was observed on the plates at any of the doses tested in either the presence or absence of S9-mix.
No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation or exposure method.
The vehicle control plates gave counts of revertant colonies within the normal range. All of the positive controls used in the test induced marked increases in the frequency of revertant colonies, both with or without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
Under the test conditions, the Reaction Mass of "Diisobutyl hydrogen phosphate and Isobutyl phosphate" (IBAP) did not show any mutagenic activity in the bacterial reverse mutation test using S. typhimurium and E. coli.
This study is considered as acceptable as it satisfied the criteria of the OECD Guideline No. 471.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
